The Europe Superdisintegrants Market published by Market Data Forecast provides a detailed account of the Market Trends via Customized Research presented as Strategic Analyses, Company Profiles, Competitive Landscape, etc.
- Advertising -
According to the report “Europe Superdisintegrants Market By Product Type (Natural Superdisintegrants, Synthetic Superdisintegrants (modified Starch, Crospovidone, Modified Cellulose, Ion Exchange Resins And Calcium Silicates), And Others), By Application (Capsules And Tablets), By Therapeutic Area (gastrointestinal Diseases, Neurological Diseases, Oncology, Infectious Diseases, Cardiovascular Diseases, Haematological Diseases, And Inflammatory Diseases), And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)” published by Market Data Forecast, The Europe Superdisintegrants Market was worth USD 71.5 million in 2016 and estimated to be growing at a CAGR of 7.2%, to reach USD 101.3 million by 2021. Increasing healthcare expenditure and healthcare awareness among individuals has accounted for the growth of this market.
Browse report details at marketdataforecast.com/market-repo…ants-market-2866/
Excipients are the substance that is fabricated alongside medicating ingredient for the purpose of long term stabilization, bulking up solid contents. Superdisintegrants are one of the type of excipients that help in fragmenting and dissolving the tablet when contacted with water.
It provides advantages like faster medicating action increased effectiveness.
- Advertising -
The factors accountable for the growth of market are growing generic drugs market, growing population of geriatric and paediatric patients and development of new superdisintegrants in pharmaceutical industry. However, the markets growth is slowed by the declining financial support for R&D fields.
Although synthetic superdisintegrants have been the standard for many decades now, greater research into natural superdisintegrants will provide a motivation for the future growth of the market.
The Europe Superdisintegrants market is segmented based on Product type, application and therapeutic area. Based on crop type – Natural and Synthetic Superdisintegrants.
Synthetic Superdisintegrants are further segmented into modified starch, crospovidone, modified cellulose, ion exchange resins and calcium silicates. Based on Application – Tablets and Capsules.
Based on Therapeutic Area – gastrointestinal diseases, neurological diseases, oncology, infectious diseases, cardiovascular diseases, haematological diseases, and inflammatory diseases.
Based on Geographical analysis the market is separated into regions of U.K., Germany, France, Italy and Spain. U.K. is leading the market while Germany is at second place.
Increasing financial support for development of innovative oral dosage forms and constant effort devoted towards providing superior quality and compliant products in the market are the primary factors responsible for the dominance of U.K and Germany in the market. Germany is expected to grow the fastest due to increasing healthcare spending, rising healthcare infrastructure and awareness.
The synthetic superdisintegrant market segment held the largest share of the Europe superdisintegrants market. This is mainly accounted to the prevalent use of excipients such as sodium starch glycolate, and crospovidone in orally and fast disintegrating tablets.
Rising incidences of cardiovascular diseases, neurological diseases, and other related diseases are further expected to drive the demand of fast disintegrating tablets, in-turn driving demand of superdisintegrants during the forecast period.
Some of the key players dominating this market include Ashland, BASF SE, FMC Corporation, JRS Pharma, DFE Pharma, Roquette, The Dow Chemical Company, Asahi Kasei Corporation, Nippon Soda Co., and Huber Corporation.
Category: Market Research Publishers and RetailersCompany profile: Market Data Forecast is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extens ...
For more information: